Poolbeg Pharma, the infectious disease pharmaceutical company, has commenced trading on the OTCQB exchange in the US, which is also called ‘the venture market’.
The company, which was spun out of Dublin-headquartered Open Orphan last year and is developing a treatment for severe influenza, hopes the new listing will improve liquidity in its share trading. Poolbeg Pharma raised almost €30 million in July last year after its initial public offering on the London...
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: